文献速递关节外科运动医学

反式肩关节置换治疗肩袖撕裂关节病:翻修或患者报告结局更差的相关因素:丹麦肩关节置换登记研究

What Factors are Associated with Revision or Worse Patient-reported Outcome after Reverse Shoulder Arthroplasty for Cuff-tear Arthropathy? A Study from the Danish Shoulder Arthroplasty Registry.
PubMed 文献 · Clin Orthop Relat Res · 2020-01-01

基于丹麦肩关节置换登记系统2006至2015年因肩袖撕裂关节病行反式肩关节置换的患者,评估10年累计翻修率及术后1年患者报告结局的相关因素。结果显示10年累计翻修率为8.5%,Delta Mark III假体翻修风险高于Delta Xtend(HR 2.7),男性翻修风险高于女性(HR 2.7);仅既往手术与更差的WOOS评分相关(平均差-10.6)。

要点

  • Delta Mark III假体翻修风险是Delta Xtend的2.7倍,男性翻修风险是女性的2.7倍。
  • 仅既往手术与术后1年更差WOOS评分独立相关,平均差-10.6。

核心结论

  • 反式肩关节置换治疗肩袖撕裂关节病10年累计翻修率为8.5%,翻修风险与假体模型和性别相关,功能结局仅与既往手术相关。

研究设计与样本

  • 基于丹麦肩关节置换登记系统2006至2015年所有因肩袖撕裂关节病行反式肩关节置换的患者,登记完整性为93%。
  • 采用Kaplan-Meier法估算翻修率,Cox回归模型计算风险比,术后12个月(范围10-14个月)邮寄问卷评估WOOS指数。
  • WOOS问卷共19题,总分0-1900分,转换为百分比(100为最佳),应答率为71%。

主要发现

  • 10年累计翻修率为8.5%(95%CI 5.7%-11.3%),Delta Mark III为21.0%(95%CI 11.8%-30.8%),Delta Xtend为5.5%(95%CI 3.7%-7.3%)。
  • 女性10年累计翻修率为6.0%(95%CI 3.0%-9.0%),男性为13.1%(95%CI 7.1%-19.1%)。
  • 控制混杂因素后,Delta Mark III较Delta Xtend翻修风险更高(HR 2.7;95%CI 1.3-5.4;p<0.01),男性较女性翻修风险更高(HR 2.7;95%CI 1.6-4.7;p<0.01)。
  • 控制混杂因素后,仅既往手术与更差WOOS评分相关(平均差-10.6;95%CI -15.2至-5.9;p<0.01),性别、假体模型、年龄组和手术时期与WOOS评分无关联。

关键数值与推荐

  • WOOS评分无明确最小临床重要差异,丹麦肩关节置换登记系统多年来将10分及以上的差异视为临床相关。

临床怎么用

  • 研究结果可用于告知患者个体化的翻修风险和功能结局预期。
  • 需注重患者选择和手术技术细节以降低翻修风险,尤其是男性患者。

局限性

  • 随访时间短,仅提供10年翻修率的估算值。
  • 需要长期随访研究证实结果。
  • 证据等级为III级,治疗性研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Reverse shoulder arthroplasty has been proven to improve function in shoulders with cuff-tear arthropathy, but existing studies are primarily single-center studies with a small number of patients, which limits their ability to identify patients who have an increased risk of revision or a worse functional outcome. QUESTIONS/PURPOSES: (1) What is the estimated 10-year cumulative revision rate after reverse shoulder arthroplasty for cuff-tear arthropathy, and what factors are associated with the risk of revision? (2) What is the patient-reported outcome 1 year after surgery, and what factors are associated with a worse patient-reported outcome? METHODS: We included all patients treated with reverse shoulder arthroplasty for cuff-tear arthropathy reported in the Danish Shoulder Arthroplasty Registry from 2006 to 2015. During the study period, the completeness of reporting was 93% for both primary and revision arthroplasties. Estimated revision rates were illustrated using the Kaplan-Meier method, and hazard ratios were calculated using a Cox regression model. Patient-reported outcome was measured with a postal survey at 12 months (range 10-14 months) postoperatively using the Western Ontario Osteoarthritis of the Shoulder (WOOS) index. The WOOS is a patient-administered questionnaire that measures the quality of life of patients with glenohumeral osteoarthritis. A visual analog scale that ranges from 0 to 100 is used for each question. There are 19 questions, giving a total score ranging from 0 to 1900, with 1900 being the worst. For simplicity of presentation, raw scores were converted to a percentage of the maximum score, with 100 being the best. There is no defined minimal clinically important difference of the WOOS, but the Danish Shoulder arthroplasty registry has for many years regarded an arbitrary difference of 10 or above as being clinically relevant. The rate of response to the WOOS was 71%. RESULTS: The estimated 10-year cumulative revision rate was 8.5% (95% confidence interval, 5.7%-11.3%) with differences between the arthroplasty model (21.0%; 95% CI, 11.8% to 30.8% for the Delta Mark III and 5.5%; 95% CI, 3.7% to 7.3% for the Delta Xtend) and gender (6.0%; 95% CI, 3.0% to 9.0% for women and 13.1%; 95% CI, 7.1% to 19.1% for men). After controlling for potential confounding variables including gender, previous surgery, arthroplasty model, and period of surgery, the risk of revision was higher with the Delta Mark III than with the Delta Xtend (hazard ratio 2.7; 95% CI, 1.3 to 5.4; p < 0.01) and higher in men than in women (hazard ratio 2.7; 95% CI, 1.6 to 4.7; p < 0.01). Thirty-three percent (19 of 57) of the revision arthroplasties were performed for dislocation and 32% (18 of 57) were to treat periprosthetic joint infection. After controlling for confounding variables, only previous surgery was associated with a worse WOOS score (mean difference -10.6; 95% CI, -15.2 to -5.9; p < 0.01); there were no associations between a worse score and gender, arthroplasty model, age group, or period of surgery. CONCLUSIONS: The results from the present study can be used to inform patients about their individual risk of revision or a disappointing functional outcome. The study also demonstrates the need for proper patient selection and attention to technical details to reduce the risk of revision, especially for men. Our follow-up time was, however, short, with only an estimate of the 10-year revision rate. Future studies with a long-term follow-up duration are needed to confirm our results. LEVEL OF EVIDENCE: Level III, therapeutic study.

来源:Clin Orthop Relat Res,查看原文。版权归原作者所有。

引用

  1. Baram A, Ammitzboell M, Brorson S, et al. What Factors are Associated with Revision or Worse Patient-reported Outcome after Reverse Shoulder Arthroplasty for Cuff-tear Arthropathy? A Study from the Danish Shoulder Arthroplasty Registry. Clin Orthop Relat Res. 2020. PMID: 31899740. doi:10.1097/CORR.0000000000001114

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。